Faes Farma, S.A. (FAE)
BME
Closed
Oct 7, 2026
Day's Range
4.7352 wk Range
4.32Overview - FAE - Faes Farma, S.A.
Key Statistics
Valuation
Enterprise Value
1.72B
P/E (Trailing)
‪16.79‬
P/E (Forward)
‪12.86‬
PEG Ratio
‪12.86‬
Price / Sales (TTM)
‪1.98‬
Price / Book
‪1.82‬
EV / EBITDA
‪13.68‬
Profitability
Gross Margin
‪63.92%‬
Profit Margin
‪11.83%‬
Operating Margin
‪17.03%‬
Return on Assets
‪5.02%‬
Return on Equity
‪11.22%‬
Ownership
Shares Outstanding
311.45M
Float
218.32M
Held by Insiders
‪20.35%‬
Held by Institutions
‪15.57%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪4.55‬
200-Day Avg
‪4.75‬
Dividends
Payout Ratio
‪66.79%‬
Frequency
Semi-Annual
Analyst Consensus
4 analysts
Average price target
‪€ 5.36‬Market Cap - FAE - Faes Farma, S.A.
Peers - FAE - Faes Farma, S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BME.
Profile Summary - FAE - Faes Farma, S.A.
About
Faes Farma, S.A. is a publicly traded Spanish pharmaceutical company founded in 1933, specializing in the research, development, production, and marketing of pharmaceutical products, healthcare items, over-the-counter medicines, food supplements, personal care treatments, and raw materials for the pharmaceutical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
